Back to Authors

Wang, Zejing

0000-0002-2212-8318

Mayo Clinic

Seagen (United States)

Citations 1

SEA-CD40, a non-fucosylated CD40 agonist: Interim results from a phase 1 study in advanced solid tumors.
Curti, Brendan D. , Smith, David C. , Rixe, Olivier , Bajor, David L. , Gutierrez, Martin , Kuzel, Timothy M. , Amore, Benny , Grilley‐Olson, Juneko E. , Goel, Sanjay , Gajewski, Thomas Frank , Markovic, Svetomir N. , Mehta, Amitkumar , Guerrero, Abraham, Wang, Zejing , Coveler, Andrew L.

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 3093-3093

10.1200/jco.2018.36.15_suppl.3093 Get It